Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - HUMAN GENOME SCIENCES INC | c10742exv99w2.htm |
| EX-99.1 - EXHIBIT 99.1 - HUMAN GENOME SCIENCES INC | c10742exv99w1.htm |
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 10, 2011
HUMAN GENOME SCIENCES,
INC.
(Exact name of registrant as
specified in its charter)
| Delaware | 001-14169 | 22-3178468 | ||
| (State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 14200 Shady Grove Road,
Rockville, Maryland |
20850-7464 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (301) 309-8504
| (Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On January 10, 2011, the Company issued the press release attached as Exhibit 99.1 to this Form 8-K, which includes priority goals for 2011 and a business update and reaffirms the Company’s previously disclosed guidance regarding cash and investments at year-end 2010.
Item 7.01. Regulation FD Disclosure.
During the week of January 10, 2011, representatives of Human Genome Sciences, Inc. will be attending meetings with investors, analysts and others at the J.P. Morgan Healthcare Conference in San Francisco, California, and will be presenting at the conference on Monday, January 10, 2011, at 3:30 p.m. Pacific time (6:30 p.m. Eastern time). During these meetings and the presentation, the Company will present the slides attached as Exhibit 99.2 to this Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Press Release, dated January 10, 2011
99.2 Slide Presentation, dated January 10, 2011
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HUMAN GENOME SCIENCES, INC.
By: /s/ James H. Davis, Ph.D.
Name:
James H. Davis, Ph.D.
Title: Executive Vice President, General
Counsel
and Secretary
Date: January 10, 2011
INDEX TO EXHIBITS
| Exhibit No. | Description | |
|
99.1
|
Press Release, dated January 10, 2011 | |
|
99.2
|
Slide Presentation, dated January 10, 2011 | |